The National Medical Products Administration (NMPA) has issued a new notification aimed at enhancing the management of import and export licenses for anesthetic drugs and psychotropic substances. Effective immediately, applicants for such permits are required to submit their application materials and supplementary materials in electronic form, eliminating the need for paper submissions. Concurrently, the drug business application system will push electronic documents for administrative licensing applications, and paper documents will cease to be issued. The NMPA will now only issue electronic permits, marking a shift towards a fully digital process for the management of these controlled substances.
This move is part of broader efforts to streamline administrative procedures and improve efficiency within the pharmaceutical sector. The transition to electronic documentation is expected to expedite the licensing process, reduce paperwork, and enhance transparency in the handling of anesthetic drugs and psychotropic substances, which are subject to strict regulatory controls due to their potential for abuse and addiction.- Flcube.com
